These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24244639)

  • 41. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
    Le Jemtel TH; Padeletti M; Jelic S
    J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma activity of B-type natriuretic peptide in patients with biventricular heart failure versus those with right heart failure due to chronic obstructive pulmonary disease.
    Flessas N; Alexanian I; Parissis J; Kremastinos D; Lekakis J; Filippatos G
    J Cardiovasc Med (Hagerstown); 2014 Jun; 15(6):476-80. PubMed ID: 24983267
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
    Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study.
    Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M
    Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myocardial perfusion reserve is impaired in patients with chronic obstructive pulmonary disease: a comparison to current smokers.
    Nakamori S; Onishi K; Ishida M; Nakajima H; Yamada T; Nagata M; Kitagawa K; Dohi K; Nakamura M; Sakuma H; Ito M
    Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):180-8. PubMed ID: 23839654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The preserved autonomic functions may provide the asymptomatic clinical status in heart failure despite advanced left ventricular systolic dysfunction.
    Kocaman SA; Taçoy G; Ozdemir M; Açıkgöz SK; Cengel A
    Anadolu Kardiyol Derg; 2010 Dec; 10(6):519-25. PubMed ID: 20952357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD.
    Urban MH; Eickhoff P; Funk GC; Burghuber OC; Wolzt M; Valipour A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():169-176. PubMed ID: 28115840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
    Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
    de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
    Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
    Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
    Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
    Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
    Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Airflow limitation in smokers is associated with subclinical atherosclerosis.
    Iwamoto H; Yokoyama A; Kitahara Y; Ishikawa N; Haruta Y; Yamane K; Hattori N; Hara H; Kohno N
    Am J Respir Crit Care Med; 2009 Jan; 179(1):35-40. PubMed ID: 18931335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Systemic inflammatory profile of smokers with and without COPD].
    Mosrane Y; Bougrida M; Alloui AS; Martani M; Rouabah L; Bourahli MK; Mehdioui H; Ben Saad H
    Rev Pneumol Clin; 2017 Sep; 73(4):188-198. PubMed ID: 28838624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.
    Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carone M; Magni G; Ambrosino N; Tavazzi L;
    Eur J Prev Cardiol; 2017 Apr; 24(6):567-576. PubMed ID: 28067533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic inflammation in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention.
    Zhang XL; Chi YH; Wang le F; Wang HS; Lin XM
    Respirology; 2014 Jul; 19(5):723-9. PubMed ID: 24750361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [C-reactive protein levels in patients with chronic obstructive pulmonary disease and asthma].
    Urboniene D; Sakalauskas R; Sitkauskiene B
    Medicina (Kaunas); 2008; 44(11):833-40. PubMed ID: 19124959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death.
    Pellicori P; Zhang J; Cuthbert J; Urbinati A; Shah P; Kazmi S; Clark AL; Cleland JGF
    Cardiovasc Res; 2020 Jan; 116(1):91-100. PubMed ID: 31350553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.